In a recent study, a decrease in opioid dispensing was observed among youths undergoing surgical procedures, but rates remained high enough to warrant additional action.

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

In this 4-part interview, Kingsberg discusses the phase 2 RECONNECT trial assessing RE104 as the potentially first psychedelic to treat postpartum depression.

In a recent study, significantly more urology websites contained information about male sexual dysfunction when compared to the availability of female sexual dysfunction information on ob-gyn websites.

In a recent study, sexual functioning outcomes were significantly improved in patients receiving hysterectomy, regardless of cervix preservation status.

A new study shows that breast arterial calcification detected on routine mammograms could help predict cardiovascular events such as heart attacks and strokes, particularly in younger women.

In a recent study, patients with shunt complications rarely had poor obstetric outcomes, and no cases of shunt malfunction were reported.

Find out what’s new and what this means for your practice.

In a recent study presented at the 25th Annual Fall Scientific Meeting of SMSNA, similar diagnosing success was reported between self-diagnosis and diagnosis from a health care provider for vaginismus.

Erika Hamilton, MD, discusses concerning increases in breast cancer incidence among younger women and certain ethnic groups, while highlighting new innovations in detection and targeted therapies that offer hope for improved patient outcomes.

From screening, to workup and treatment, find out how to provide the best course of action for your pregnant patients with anemia.

In a recent study, mothers and fathers with simultaneous parental leave after birth were more likely to utilize mental health care services than those without simultaneous parental leave.

Elinzanetant, a non-hormonal drug, shows promising results in reducing hot flashes and night sweats, offering a new option for women seeking effective and safe treatment for vasomotor symptoms.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

From the eradication of smallpox to the COVID-19 pandemic, vaccines have revolutionized health care, but rising vaccine hesitancy now threatens progress, especially among pregnant women.

Research reveals that over a third of adolescents in pediatric emergency departments struggle with access to menstrual products, highlighting the need for improved public health measures.

The New Drug Application (NDA) acceptance is supported by positive data from 3 clinical trials (OASIS 1, 2, and 3).

Despite an increase in mifepristone use to manage early pregnancy loss over time, rates remain low, preventing patients from receiving proven benefits.

In a recent study, multiple reproductive health factors were linked to breast cancer incidence among women in the Caribbean.

In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.

In a recent study, postmenopausal women in lower Tertiles of Estradiol concentration experienced an increased prevalence of abdominal aortic calcification.

In a recent study, approximately half of infective endocarditis cases were women who inject drugs, despite only one-third of people who inject drugs being women.

In a recent study, cardiovascular severe maternal morbidity was significantly more common in patients with hypertensive disorders of pregnancy vs those without.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.